{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:40:14Z","timestamp":1790221214911,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.drup.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T14:41:49Z","timestamp":1517496109000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra"],"prefix":"10.1016","volume":"37","author":[{"given":"Dimitri","family":"Topalis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gillemot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2018.01.003_bib0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/prep.2000.1201","article-title":"Highly purified recombinant varicella Zoster virus thymidine kinase is a homodimer","volume":"18","author":"Amrhein","year":"2000","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.drup.2018.01.003_bib0010","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1128\/JVI.79.9.5863-5869.2005","article-title":"Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin","volume":"79","author":"Andrei","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0015","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/JVI.06620-11","article-title":"In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs","volume":"86","author":"Andrei","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling","volume":"22","author":"Arnold","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drup.2018.01.003_bib0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-3542(97)00026-0","article-title":"Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus","volume":"35","author":"Ashida","year":"1997","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0030","doi-asserted-by":"crossref","first-page":"29593","DOI":"10.1074\/jbc.M202312200","article-title":"Specific phosphorylation of exogenous protein and peptide substrates by the human cytomegalovirus UL97 protein kinase. Importance of the P\u202f+\u202f5 position","volume":"277","author":"Baek","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virol.2004.03.015","article-title":"Phosphorylation of the RNA polymerase II carboxyl-terminal domain in human cytomegalovirus-infected cells and in vitro by the viral UL97 protein kinase","volume":"324","author":"Baek","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.drup.2018.01.003_bib0040","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1021\/bi0255930","article-title":"The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase","volume":"41","author":"Balzarini","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.drup.2018.01.003_bib0045","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/sj.gt.3301779","article-title":"Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines","volume":"9","author":"Balzarini","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.drup.2018.01.003_bib0050","doi-asserted-by":"crossref","first-page":"19273","DOI":"10.1074\/jbc.M600414200","article-title":"Engineering of a single conserved amino acid residue of herpes simplex virus type 1 thymidine kinase allows a predominant shift from pyrimidine to purine nucleoside phosphorylation","volume":"281","author":"Balzarini","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0055","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1099\/vir.0.022293-0","article-title":"Modification of the major tegument protein pp65 of human cytomegalovirus inhibits virus growth and leads to the enhancement of a protein complex with pUL69 and pUL97 in infected cells","volume":"91","author":"Becke","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-5793(98)01619-6","article-title":"Structure to 1.9\u202fA resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallographic comparison with binding of aciclovir","volume":"443","author":"Bennett","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drup.2018.01.003_bib0065","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0070","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.46.8.2365-2372.2002","article-title":"Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action","volume":"46","author":"Biron","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/095632020801900101","article-title":"Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutations","volume":"19","author":"Biswas","year":"2008","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0080","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00705-007-0964-7","article-title":"Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture","volume":"152","author":"Biswas","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jac\/dkm182","article-title":"Detection of HSV-1 variants highly resistant to the helicase-primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1","volume":"60","author":"Biswas","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0090","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/jac\/dkn057","article-title":"A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral target","volume":"61","author":"Biswas","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2008.04.005","article-title":"Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity","volume":"80","author":"Biswas","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0100","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1099\/vir.0.011221-0","article-title":"A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structure","volume":"90","author":"Biswas","year":"2009","journal-title":"J. Gen. Virol."},{"issue":"Pt 7","key":"10.1016\/j.drup.2018.01.003_bib0105","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1099\/0022-1317-77-7-1521","article-title":"Effect on substrate binding of an alteration at the conserved aspartic acid-162 in herpes simplex virus type 1 thymidine kinase","volume":"77","author":"Black","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1874091X00701010033","article-title":"High G\u202f+\u202fC content of herpes simplex virus DNA: proposed role in protection against retrotransposon insertion","volume":"1","author":"Brown","year":"2007","journal-title":"Open Biochem. J."},{"key":"10.1016\/j.drup.2018.01.003_bib0115","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ije\/26.4.698","article-title":"Genital herpes infection: a review","volume":"26","author":"Brugha","year":"1997","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.drup.2018.01.003_bib0120","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.05115-14","article-title":"Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate","volume":"59","author":"Brunnemann","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0125","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.antiviral.2012.09.016","article-title":"Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity","volume":"96","author":"Burrel","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2011.03.003","article-title":"Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients","volume":"305","author":"Cesarman","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2018.01.003_bib0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/(SICI)1097-0134(19980815)32:3<350::AID-PROT10>3.0.CO;2-8","article-title":"Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands","volume":"32","author":"Champness","year":"1998","journal-title":"Proteins"},{"key":"10.1016\/j.drup.2018.01.003_bib0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0026-895X(25)13899-6","article-title":"Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins","volume":"20","author":"Cheng","year":"1981","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drup.2018.01.003_bib0145","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/AAC.00577-06","article-title":"Maribavir antagonizes the antiviral action of ganciclovir on human cytomegalovirus","volume":"50","author":"Chou","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/JVI.01787-07","article-title":"Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant","volume":"82","author":"Chou","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/518514","article-title":"Cytomegalovirus UL97 kinase mutations that confer maribavir resistance","volume":"196","author":"Chou","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2018.01.003_bib0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2012.05.013","article-title":"Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo","volume":"95","author":"Chou","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0165","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/AAC.00511-13","article-title":"Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance","volume":"57","author":"Chou","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0170","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1128\/JCM.00391-17","article-title":"Differentiated Levels of Ganciclovir Resistance Conferred by Mutations at Codons 591\u2013603 of the Cytomegalovirus UL97 Kinase Gene","volume":"55","author":"Chou","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2018.01.003_bib0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/rmv.574","article-title":"Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir","volume":"18","author":"Chou","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/QCO.0000000000000170","article-title":"Approach to drug-resistant cytomegalovirus in transplant recipients","volume":"28","author":"Chou","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.drup.2018.01.003_bib0185","doi-asserted-by":"crossref","first-page":"12422","DOI":"10.1128\/JVI.02231-13","article-title":"Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells","volume":"87","author":"Coen","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0190","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1128\/AAC.03957-14","article-title":"Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses","volume":"58","author":"Coen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcv.2011.08.003","article-title":"Current management and recommendations for access to antiviral therapy of herpes labialis","volume":"53","author":"Cunningham","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro958","article-title":"Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis","volume":"2","author":"Damania","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drup.2018.01.003_bib0205","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/mol.62.3.714","article-title":"Role of the human herpesvirus 6 u69-encoded kinase in the phosphorylation of ganciclovir","volume":"62","author":"De Bolle","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drup.2018.01.003_bib0210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1081\/NCN-100002298","article-title":"Acyclic\/carbocyclic guanosine analogues as anti-herpesvirus agents","volume":"20","author":"De Clercq","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"Suppl. A","key":"10.1016\/j.drup.2018.01.003_bib0215","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/32.suppl_A.121","article-title":"Antivirals for the treatment of herpesvirus infections","volume":"32","author":"De Clercq","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0220","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1080\/15257770008045444","article-title":"Guanosine analogues as anti-herpesvirus agents","volume":"19","author":"De Clercq","year":"2000","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.drup.2018.01.003_bib0225","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3851\/IMP2818","article-title":"Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature","volume":"20","author":"Deback","year":"2015","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.drup.2018.01.003_bib0230","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1124\/mol.58.6.1326","article-title":"Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine","volume":"58","author":"Degreve","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drup.2018.01.003_bib0235","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/mol.59.2.285","article-title":"Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase","volume":"59","author":"Degreve","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drup.2018.01.003_bib0240","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2010.02.001","article-title":"Human and viral nucleoside\/nucleotide kinases involved in antiviral drug activation: structural and catalytic properties","volume":"86","author":"Deville-Bonne","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0166-3542(97)00027-2","article-title":"Metabolism and activities of 3'-azido-2',3'-dideoxythymidine and 2',3'-didehydro-2',3'-dideoxythymidine in herpesvirus thymidine kinase transduced T-lymphocytes","volume":"35","author":"Drake","year":"1997","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0250","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jiw129","article-title":"No evidence of pritelivir resistance among herpes simplex virus type 2 isolates after 4 weeks of daily therapy","volume":"214","author":"Edlefsen","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2018.01.003_bib0255","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1124\/mol.106.023002","article-title":"Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design","volume":"69","author":"El Omari","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drup.2018.01.003_bib0260","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00018-002-8511-x","article-title":"Structure and function of cellular deoxyribonucleoside kinases","volume":"59","author":"Eriksson","year":"2002","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.drup.2018.01.003_bib0265","doi-asserted-by":"crossref","first-page":"S621","DOI":"10.1042\/bst025s621","article-title":"Structure-specificity features of HSV-1 thymidine kinases","volume":"25","author":"Evans","year":"1997","journal-title":"Biochem. Soc. Trans."},{"issue":"Pt 9","key":"10.1016\/j.drup.2018.01.003_bib0270","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1099\/0022-1317-79-9-2083","article-title":"Herpesviral thymidine kinases: laxity and resistance by design","volume":"79","author":"Evans","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0275","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0166-3542(02)00094-3","article-title":"Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus","volume":"56","author":"Evers","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2014.08.013","article-title":"Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France","volume":"111","author":"Frobert","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0285","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/QCO.0000000000000375","article-title":"Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options","volume":"30","author":"Fuji","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.drup.2018.01.003_bib0290","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1073\/pnas.83.21.8333","article-title":"Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase","volume":"83","author":"Furman","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drup.2018.01.003_bib0295","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.1016\/S0021-9258(17)34236-9","article-title":"Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine","volume":"253","author":"Fyfe","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0300","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1099\/vir.0.039214-0","article-title":"Human cytomegalovirus UL97 kinase alters the accumulation of CDK1","volume":"93","author":"Gill","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0305","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.csbj.2015.01.003","article-title":"Antiviral drug- and multidrug resistance in cytomegalovirus infected SCT patients","volume":"13","author":"Gohring","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"Suppl. 1","key":"10.1016\/j.drup.2018.01.003_bib0310","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1002\/elps.200900140","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective","volume":"30","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.drup.2018.01.003_bib0315","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1128\/AAC.42.11.2923","article-title":"The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase","volume":"42","author":"Gustafson","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0320","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/JVI.74.2.684-692.2000","article-title":"Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir","volume":"74","author":"Gustafson","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0325","doi-asserted-by":"crossref","first-page":"e1000275","DOI":"10.1371\/journal.ppat.1000275","article-title":"Viral mimicry of Cdc2\/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress","volume":"5","author":"Hamirally","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drup.2018.01.003_bib0330","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"Drug-resistant cytomegalovirus in transplant recipients: a French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0335","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/JVI.71.1.405-411.1997","article-title":"The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines","volume":"71","author":"He","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0340","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1021\/bi992453q","article-title":"Conservative mutations of glutamine-125 in herpes simplex virus type 1 thymidine kinase result in a ganciclovir kinase with minimal deoxypyrimidine kinase activities","volume":"39","author":"Hinds","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.drup.2018.01.003_bib0345","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcv.2017.08.011","article-title":"Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades","volume":"95","author":"Hoffmann","year":"2017","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0350","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fmicb.2016.01317","article-title":"Detection of low frequency multi-drug resistance and novel putative maribavir resistance in immunocompromised pediatric patients with cytomegalovirus","volume":"7","author":"Houldcroft","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drup.2018.01.003_bib0355","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jchromb.2006.09.018","article-title":"Development and validation of a capillary electrophoresis method for the characterization of herpes simplex virus type 1 (HSV-1) thymidine kinase substrates and inhibitors","volume":"846","author":"Iqbal","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.drup.2018.01.003_bib0360","doi-asserted-by":"crossref","first-page":"19666","DOI":"10.1074\/jbc.M115.660043","article-title":"Molecular determinants for the inactivation of the retinoblastoma tumor suppressor by the viral cyclin-dependent kinase UL97","volume":"290","author":"Iwahori","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0365","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1074\/jbc.M116.773150","article-title":"Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins","volume":"292","author":"Iwahori","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0370","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/cpt.3","article-title":"Helicase-primase as a target of new therapies for herpes simplex virus infections","volume":"97","author":"James","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drup.2018.01.003_bib0375","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cbdv.200690030","article-title":"Synthesis and characterization of a C6 nucleoside analogue for the in vivo imaging of the gene expression of herpes simplex virus type-1 thymidine kinase (HSV1 TK)","volume":"3","author":"Johayem","year":"2006","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.drup.2018.01.003_bib0380","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1128\/JVI.01681-07","article-title":"Inhibition of the cyclin-dependent kinases at the beginning of human cytomegalovirus infection specifically alters the levels and localization of the RNA polymerase II carboxyl-terminal domain kinases cdk9 and cdk7 at the viral transcriptosome","volume":"82","author":"Kapasi","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jnnp.73.3.237","article-title":"Herpes simplex encephalitis","volume":"73","author":"Kennedy","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.drup.2018.01.003_bib0390","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s13365-013-0178-6","article-title":"Recent issues in herpes simplex encephalitis","volume":"19","author":"Kennedy","year":"2013","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.drup.2018.01.003_bib0395","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1128\/AAC.48.5.1749-1755.2004","article-title":"Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infections","volume":"48","author":"Kern","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0400","doi-asserted-by":"crossref","first-page":"D387","DOI":"10.1093\/nar\/gkn750","article-title":"The SWISS-MODEL repository and associated resources","volume":"37","author":"Kiefer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0405","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40265-017-0860-8","article-title":"Letermovir: first global approval","volume":"78","author":"Kim","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.drup.2018.01.003_bib0410","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1128\/AAC.31.10.1483","article-title":"Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir","volume":"31","author":"Kit","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0415","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1110\/ps.2460102","article-title":"Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity","volume":"11","author":"Kokoris","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.drup.2018.01.003_bib0420","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/AAC.01726-13","article-title":"Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions","volume":"58","author":"Komazin-Meredith","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0425","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1056\/NEJM199312093292405","article-title":"Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient","volume":"329","author":"Kost","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"Dec. (12)","key":"10.1016\/j.drup.2018.01.003_bib0430","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1111\/bcp.13376","article-title":"Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment","volume":"83","author":"Kropeit","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drup.2018.01.003_bib0435","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1128\/JVI.77.14.7720-7727.2003","article-title":"The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase","volume":"77","author":"Krosky","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0440","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1432-1327.1998.2550472.x","article-title":"Drug resistance of herpes simplex virus type 1-structural considerations at the molecular level of the thymidine kinase","volume":"255","author":"Kussmann-Gerber","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.drup.2018.01.003_bib0445","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/358160a0","article-title":"Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir","volume":"358","author":"Littler","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.drup.2018.01.003_bib0450","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1128\/AAC.39.8.1802","article-title":"Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses","volume":"39","author":"Lowe","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0455","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0042-6822(03)00147-8","article-title":"The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44","volume":"311","author":"Marschall","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.drup.2018.01.003_bib0460","doi-asserted-by":"crossref","first-page":"33357","DOI":"10.1074\/jbc.M502672200","article-title":"Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina","volume":"280","author":"Marschall","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0465","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2018.01.003_bib0470","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1128\/JVI.02487-09","article-title":"The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production","volume":"84","author":"Meng","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0475","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/protein\/15.11.903","article-title":"Mutation of herpesvirus thymidine kinase to generate ganciclovir-specific kinases for use in cancer gene therapies","volume":"15","author":"Mercer","year":"2002","journal-title":"Protein Eng."},{"key":"10.1016\/j.drup.2018.01.003_bib0480","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1086\/315696","article-title":"Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients","volume":"182","author":"Morfin","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2018.01.003_bib0485","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1096-9071(200010)62:2<247::AID-JMV17>3.0.CO;2-V","article-title":"Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene","volume":"62","author":"Morfin","year":"2000","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0490","doi-asserted-by":"crossref","first-page":"9032","DOI":"10.1016\/S0021-9258(18)31547-3","article-title":"Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides","volume":"266","author":"Munch-Petersen","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0495","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jviromet.2009.06.016","article-title":"Detection and identification of U69 gene mutations encoded by ganciclovir-resistant human herpesvirus 6 using denaturing high-performance liquid chromatography","volume":"161","author":"Nakano","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.drup.2018.01.003_bib0500","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.gene.2012.02.049","article-title":"High GC content of simple sequence repeats in Herpes simplex virus type 1 genome","volume":"499","author":"Ouyang","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.drup.2018.01.003_bib0505","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1099\/0022-1317-81-4-1067","article-title":"Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 36 protein is a serine protein kinase","volume":"81","author":"Park","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0510","doi-asserted-by":"crossref","first-page":"31967","DOI":"10.1074\/jbc.274.45.31967","article-title":"Substrate diversity of herpes simplex virus thymidine kinase. Impact Of the kinematics of the enzyme","volume":"274","author":"Pilger","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0515","doi-asserted-by":"crossref","first-page":"31967","DOI":"10.1074\/jbc.274.45.31967","article-title":"Substrate diversity of herpes simplex virus thymidine kinase. Impact Of the kinematics of the enzyme","volume":"274","author":"Pilger","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0520","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0525","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1128\/AAC.01447-06","article-title":"Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase","volume":"51","author":"Prichard","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0530","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/AAC.01523-10","article-title":"Benzimidazole analogs inhibit human herpesvirus 6","volume":"55","author":"Prichard","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0535","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/rmv.615","article-title":"Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir","volume":"19","author":"Prichard","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0540","doi-asserted-by":"crossref","first-page":"9597","DOI":"10.1021\/bi000668q","article-title":"Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine","volume":"39","author":"Prota","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.drup.2018.01.003_bib0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.11.002","article-title":"Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis","volume":"149","author":"Quenelle","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0550","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1128\/JVI.65.12.6407-6413.1991","article-title":"Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment","volume":"65","author":"Roberts","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0555","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/0006-2952(93)90611-Y","article-title":"Varicella-zoster virus thymidine kinase. Characterization and substrate specificity","volume":"46","author":"Roberts","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drup.2018.01.003_bib0560","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1021\/jm060696s","article-title":"Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation","volume":"49","author":"Romaker","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0565","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jmv.10510","article-title":"Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase","volume":"71","author":"Safronetz","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0570","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0166-3542(02)00131-6","article-title":"Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain","volume":"56","author":"Saijo","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0575","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1128\/JVI.71.5.3872-3878.1997","article-title":"Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir","volume":"71","author":"Sasadeusz","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0580","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/dkv285","article-title":"Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2","volume":"71","author":"Sauerbrei","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0585","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/abio.2001.5191","article-title":"A spectrophotometric assay for quantitative determination of kcat of herpes simplex virus type 1 thymidine kinase substrates","volume":"295","author":"Schelling","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.drup.2018.01.003_bib0590","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1086\/314900","article-title":"Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed","volume":"180","author":"Schmit","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2018.01.003_bib0595","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1099\/vir.0.82393-0","article-title":"Mapping of a self-interaction domain of the cytomegalovirus protein kinase pUL97","volume":"88","author":"Schregel","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0600","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1128\/AAC.47.4.1468-1471.2003","article-title":"Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication","volume":"47","author":"Selleseth","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0605","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1021\/jm00100a029","article-title":"L-Thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth","volume":"35","author":"Spadari","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2018.01.003_bib0610","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11910-013-0414-8","article-title":"Update on herpes virus infections of the nervous system","volume":"13","author":"Steiner","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.drup.2018.01.003_bib0615","first-page":"8","article-title":"Proteomic interaction patterns between human cyclins, the cyclin-dependent kinase ortholog pUL97 and additional cytomegalovirus proteins","author":"Steingruber","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.drup.2018.01.003_bib0620","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2010.04.008","article-title":"Effects of therapy using a helicase-primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant","volume":"87","author":"Sukla","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0625","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1128\/JVI.67.2.1024-1033.1993","article-title":"Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS","volume":"67","author":"Talarico","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0630","doi-asserted-by":"crossref","first-page":"15477","DOI":"10.1128\/JVI.79.24.15477-15493.2005","article-title":"Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7","volume":"79","author":"Tamrakar","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0635","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1099\/vir.0.005827-0","article-title":"Cytomegaloviral protein kinase pUL97 interacts with the nuclear mRNA export factor pUL69 to modulate its intranuclear localization and activity","volume":"90","author":"Thomas","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.drup.2018.01.003_bib0640","first-page":"9530","article-title":"Distribution and effects of amino acid changes in drug-resistant alpha and beta herpesviruses DNA polymerase","volume":"44","author":"Topalis","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2018.01.003_bib0645","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/AAC.38.9.2175","article-title":"Substrate specificity of Epstein-Barr virus thymidine kinase","volume":"38","author":"Tung","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Pt 1","key":"10.1016\/j.drup.2018.01.003_bib0650","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1042\/bj3280317","article-title":"Relaxed enantioselectivity of human mitochondrial thymidine kinase and chemotherapeutic uses of L-nucleoside analogues","volume":"328","author":"Verri","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.drup.2018.01.003_bib0655","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1002\/pmic.200900298","article-title":"LuMPIS\u2014a modified luminescence-based mammalian interactome mapping pull-down assay for the investigation of protein\u2013protein interactions encoded by GC-low ORFs","volume":"9","author":"Vizoso Pinto","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.drup.2018.01.003_bib0660","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.4459","article-title":"The Epstein-Barr virus and the pathogenesis of lymphoma","volume":"235","author":"Vockerodt","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.drup.2018.01.003_bib0665","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMoa1301150","article-title":"Helicase-primase inhibitor pritelivir for HSV-2 infection","volume":"370","author":"Wald","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2018.01.003_bib0670","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2016.18189","article-title":"Effect of pritelivir compared with valacyclovir on genital HSV-2 shedding in patients with frequent recurrences: a randomized clinical trial","volume":"316","author":"Wald","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drup.2018.01.003_bib0675","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0014-5793(98)01711-6","article-title":"Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates","volume":"443","author":"Wang","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drup.2018.01.003_bib0680","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12250-016-3839-9","article-title":"Amino acids essential for the interaction between cellular heat shock protein 90 and a Kaposi's sarcoma-associated herpesvirus-encoded protein kinase ORF36","volume":"31","author":"Wang","year":"2016","journal-title":"Virol. Sin."},{"key":"10.1016\/j.drup.2018.01.003_bib0685","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0014-5793(95)00680-8","article-title":"The three-dimensional structure of thymidine kinase from herpes simplex virus type 1","volume":"368","author":"Wild","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drup.2018.01.003_bib0690","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/pro.5560061005","article-title":"The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue","volume":"6","author":"Wild","year":"1997","journal-title":"Protein Sci."},{"key":"10.1016\/j.drup.2018.01.003_bib0695","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/AAC.47.7.2186-2192.2003","article-title":"In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses","volume":"47","author":"Williams","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2018.01.003_bib0700","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1110\/ps.27401","article-title":"The effect of substrate binding on the conformation and structural stability of Herpes simplex virus type 1 thymidine kinase","volume":"10","author":"Wurth","year":"2001","journal-title":"Protein Sci."},{"key":"10.1016\/j.drup.2018.01.003_bib0705","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1006\/jmbi.2001.5060","article-title":"Folding and self-assembly of herpes simplex virus type 1 thymidine kinase","volume":"313","author":"Wurth","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.drup.2018.01.003_bib0710","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00705-012-1479-4","article-title":"A new mutation in the human cytomegalovirus UL97 gene may confer ganciclovir resistance in Chinese kidney transplant recipients","volume":"158","author":"Zhang","year":"2013","journal-title":"Arch. Virol."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764618300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764618300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T11:57:13Z","timestamp":1751284633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764618300037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":142,"alternative-id":["S1368764618300037"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2018.01.003","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}